What are the best eye drops for allergic conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Eye Drops for Allergic Conjunctivitis

Dual-action topical antihistamine/mast cell stabilizers are the best eye drops for allergic conjunctivitis, with olopatadine being the most effective option for symptom relief. 1

First-Line Treatment Options

Dual-action agents provide both immediate symptom relief and prevention of symptoms, making them superior to single-action medications. The recommended options include:

  • Olopatadine: Applied twice daily (ages >3 years)

    • High-concentration formulations (0.77%) show longer duration of action and better efficacy for ocular itch compared to lower concentrations 1, 2
    • Considered superior to other agents for treating ocular itch with prolonged effect when used once-daily 2
  • Ketotifen: Applied twice daily (ages >3 years)

    • Effective for reducing subjective symptoms within 10 days in 60-80% of patients 3
    • Onset of action within 20 minutes, duration of 8-13 hours 3
  • Epinastine: Applied twice daily (ages >12 years)

    • Has shown superior efficacy to placebo and equal or greater effectiveness than olopatadine 0.1% for ocular itch and conjunctival hyperemia 1, 2
  • Azelastine: Applied 2-4 times daily (ages >4 years)

    • Demonstrated effectiveness in multiple clinical trials 1, 2

For Severe or Refractory Cases

When first-line treatments are insufficient:

  • Short-term topical corticosteroids (e.g., loteprednol etabonate 0.2%):

    • Indicated for temporary relief of signs and symptoms of seasonal allergic conjunctivitis 4
    • Should only be used under ophthalmologist supervision due to risk of intraocular pressure elevation 1
    • Clinical trials show superiority to placebo in treating signs and symptoms of seasonal allergic conjunctivitis when dosed four times daily 4
    • Provides reduction in bulbar conjunctival injection and itching beginning approximately 2 hours after first dose 4
  • For long-term management of severe cases:

    • Topical cyclosporine or topical tacrolimus may be considered 1

Supportive Measures

  • Preservative-free artificial tears (2-4 times daily):

    • Help dilute allergens and inflammatory mediators 1
  • Cold compresses:

    • Reduce local pain and swelling 1
  • Environmental modifications:

    • Humidify ambient air
    • Avoid direct air drafts
    • Take regular breaks from screen time 1

Important Precautions

  • Avoid prolonged use of ocular decongestants/vasoconstrictors:

    • Can cause rebound hyperemia ("conjunctivitis medicamentosa") 1
  • Avoid punctal plugs:

    • Prevent flushing of allergens and inflammatory mediators from the ocular surface 1
  • Monitor for complications with corticosteroid use:

    • Baseline and periodic intraocular pressure measurement is recommended
    • Follow-up within 1-2 weeks for patients using topical corticosteroids 1, 4
  • Avoid first-generation oral antihistamines:

    • Can cause sedation and anticholinergic effects
    • May induce or worsen dry eye syndrome 1

Clinical Decision Algorithm

  1. Initial treatment: Start with dual-action antihistamine/mast cell stabilizer (preferably olopatadine)
  2. If inadequate response: Try alternative dual-action agent (epinastine, ketotifen, or azelastine)
  3. For severe symptoms: Consider short-term topical corticosteroids (loteprednol 0.2%) under ophthalmologist supervision
  4. For chronic management: Consider topical cyclosporine or tacrolimus for severe/refractory cases
  5. Always include: Supportive measures like artificial tears and cold compresses

The evidence strongly supports dual-action agents as the most effective treatment for allergic conjunctivitis, with olopatadine showing particular efficacy for ocular itch with longer duration of action in its higher concentration formulations 1, 2.

References

Guideline

Ocular Allergy Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Ketotifen fumarate (Zaditen) eye drops in the treatment of seasonal allergic conjunctivitis].

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.